[Against insulin resistance. Insulin sensitizers]

Pharm Unserer Zeit. 2002;31(3):280-92. doi: 10.1002/1615-1003(200205)31:3<280::AID-PAUZ280>3.0.CO;2-L.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism*
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance / physiology*
  • Pioglitazone
  • Thiazoles / adverse effects
  • Thiazoles / pharmacology
  • Thiazoles / therapeutic use*
  • Thiazolidinediones*

Substances

  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Pioglitazone